Health

Large trials for anticipated Oxford COVID-19 vaccine begin in the U.S.

Large trials for anticipated Oxford COVID-19 vaccine begin in the U.S.

Phase 3 clinical trials for the much-anticipated Oxford COVID-19 vaccine are set to begin in the United States Tuesday, with participants in Madison, Wisconsin rolling up their sleeves for the injection. he University of Wisconsin is one of dozens of test sites in the U.S. for the vaccine candidate, made by AstraZeneca in partnership with the U.K.'s University of Oxford.

Click here to read more -->
×